CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
1.040
-0.060 (-5.45%)
At close: Jun 18, 2026, 4:00 PM EDT
1.040
0.00 (0.00%)
After-hours: Jun 18, 2026, 6:30 PM EDT
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $15.07 million as of June 18, 2026. Its market cap has increased by 21.79% in one year.
Market Cap
15.07M
Enterprise Value
21.54M
1-Year Change
21.79%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since February 10, 1992, CEL-SCI's market cap has decreased from $126.81M to $15.07M, a decrease of -88.11%. That is a compound annual growth rate of -6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 15.07M | -65.92% |
| Dec 31, 2025 | 44.23M | 49.58% |
| Dec 31, 2024 | 29.57M | -78.25% |
| Dec 29, 2023 | 135.95M | 32.44% |
| Dec 30, 2022 | 102.65M | -66.57% |
| Dec 31, 2021 | 307.04M | -33.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.44M |
| Curis | 15.19M |
| Akari Therapeutics, | 14.88M |
| Citius Pharmaceuticals | 14.87M |
| Quince Therapeutics | 14.68M |
| Lexaria Bioscience | 14.60M |
| Moleculin Biotech | 14.41M |
| Exicure | 13.83M |